These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19514384)

  • 1. [Prostate cancer: evolution of approach].
    Vorob'ëv AV
    Vopr Onkol; 2009; 55(2):241-9. PubMed ID: 19514384
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of prostate cancer].
    Romics I
    Orv Hetil; 2010 Apr; 151(14):580-3. PubMed ID: 20332076
    [No Abstract]   [Full Text] [Related]  

  • 3. Current world literature.
    Curr Opin Urol; 2013 Jul; 23(4):377-88. PubMed ID: 23735869
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant hormonotherapy in patients with clinically-localized prostate cancer treated by radical prostatectomy: pathological results.
    Têtu B
    Can J Oncol; 1994 Nov; 4 Suppl 1():33-4; discussion 35-6. PubMed ID: 8853487
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combined treatment of metastatic hormone-resistant prostate cancer].
    Kaprin AD; Gafanov RA; Al'bitskiĭ IA; Fastovets SV
    Vopr Onkol; 2009; 55(4):477-9. PubMed ID: 19947375
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings of the 1st International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer. Boston, Massachusetts, March 29-30, 1996.
    Urology; 1997 Mar; 49(3A Suppl):1-118; quiz 121-3. PubMed ID: 9123726
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evolution of endocrine therapy for prostate cancer].
    Igawa T; Saito Y
    Nihon Rinsho; 2000 Jul; 58 Suppl():176-81. PubMed ID: 11022709
    [No Abstract]   [Full Text] [Related]  

  • 8. [Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].
    Berenguer Sánchez A
    Arch Esp Urol; 2002 Sep; 55(7):771-5. PubMed ID: 12380304
    [No Abstract]   [Full Text] [Related]  

  • 9. [Keyrole of endocrinology in the victory against prostate cancer].
    Labrie F
    Bull Cancer; 2006 Sep; 93(9):949-58. PubMed ID: 16980238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment options in hormone resistant prostate cancer.
    De Mulder PH; Schalken JA; Sternberg CN
    Ann Oncol; 2002; 13 Suppl 4():95-102. PubMed ID: 12401673
    [No Abstract]   [Full Text] [Related]  

  • 11. 'Clandestine' prostate cancer haunts.
    Chapman B
    CAP Today; 1996 Feb; 10(2):1, 34-6, 38 passim. PubMed ID: 10160261
    [No Abstract]   [Full Text] [Related]  

  • 12. [Novelties in diagnostics and treatment of prostate cancer].
    Riesz P; Nyírádi P
    Orv Hetil; 2016 Mar; 157(11):410-4. PubMed ID: 26947089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choice of first-line treatment for metastatic prostate cancer.
    Prescrire Int; 2013 Feb; 22(135):51. PubMed ID: 23444511
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment options in androgen-independent prostate cancer.
    Lara PN; Meyers FJ
    Cancer Invest; 1999; 17(2):137-44. PubMed ID: 10071598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sixth joint meeting of J-CaP and CaPSURE--a multinational perspective on prostate cancer management and patient outcomes.
    Akaza H; Hinotsu S; Cooperberg MR; Chung BH; Youl Lee J; Umbas R; Tsukamoto T; Namiki M; Carroll P
    Jpn J Clin Oncol; 2013 Jul; 43(7):756-66. PubMed ID: 23723314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thwarting high-risk prostate cancer: the right treatments for the right patients.
    Cooperberg MR
    Eur Urol; 2012 Jun; 61(6):1107-9. PubMed ID: 22475772
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prostate cancer: a review of therapeutic strategies].
    Winterhalder RC
    Praxis (Bern 1994); 2009 Oct; 98(20):1149-53. PubMed ID: 19809978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life after primary treatment for localized prostate cancer: long-term considerations.
    Alemozaffar M; Sanda MG
    Eur Urol; 2015 Oct; 68(4):609-10. PubMed ID: 25533419
    [No Abstract]   [Full Text] [Related]  

  • 19. The changing face of hormonal therapy for prostate cancer.
    Seruga B; Tannock IF
    Ann Oncol; 2008 Sep; 19 Suppl 7():vii79-85. PubMed ID: 18790984
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of prostate cancer].
    Imre R
    Orv Hetil; 2005 Aug; 146(35):1839-42. PubMed ID: 16187544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.